Cell Stem Cell 2017-04-06

iPSCs Meet GWAS: The NextGen Consortium

Deborah J. Sweet

Index: 10.1016/j.stem.2017.03.020

Full Text: HTML

Abstract

Disease modeling with human iPSCs has come a long way since it first began almost 10 years ago. Many of us can probably remember the time when just making an iPSC line from a patient with a recognized disease was a notable achievement. It didn’t take long, however, before expectations rose and we moved quickly past recapitulating relevant phenotypes to the situation today in which most studies aim to either teach us something substantial that we didn’t know before about a given disease or show a path to potential therapies (or, hopefully, both).

Latest Articles:

ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Suppress Tumorigenicity of Glioblastoma Stem Cells

2017-07-13

[10.1016/j.stem.2017.06.004]

Lineage Tracing: Papers and Progress

2017-07-06

[10.1016/j.stem.2017.06.015]

Intestinal Enteroendocrine Lineage Cells Possess Homeostatic and Injury-Inducible Stem Cell Activity

2017-07-06

[10.1016/j.stem.2017.06.014]

Direct Neuronal Reprogramming: Achievements, Hurdles, and New Roads to Success

2017-07-06

[10.1016/j.stem.2017.06.011]

Making HSCs on Demand: Looking Ahead

2017-07-06

[10.1016/j.stem.2017.06.010]

More Articles...